Cellular biology of myomas: Interaction of sex steroids with cytokines and growth factors

Obstetrics and Gynecology Clinics of North America

Volumn 33, Issue 1, 2006, Pages 41-58

  Sozen, Ibrahim ^a   Arici, Aydin ^b  

^a Anadolu Saglik Merkezi Hospital   (Turkey)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ANTIGESTAGEN; CYTOKINE; GESTAGEN; GONADORELIN AGONIST; GROWTH FACTOR; NEUTRALIZING ANTIBODY; PROGESTERONE; SEX HORMONE;

CELL PROLIFERATION; CLINICAL TRIAL; CYTOLOGY; DRUG MEGADOSE; HUMAN; LUNG NODULE; METASTASIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPRODUCTION; REVIEW; UTERUS MYOMA;

CYTOKINES; FEMALE; GONADAL STEROID HORMONES; GROWTH SUBSTANCES; HUMANS; LEIOMYOMA; MOLECULAR BIOLOGY; UTERINE NEOPLASMS;

EID: 33644559047     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ogc.2005.12.005     Document Type: Review

References (106)

1. H.J. Norris, and C.J. Zaloudek Mesenchymal tumors of the uterus A. Blaustein Pathology of the female genital tract 1977 Springer-Verlag New York 352 392
2. H. Matsuo, O. Kurachi, and Y. Shimomura Molecular bases for the actions of ovarian sex steroids in the regulation of proliferation and apoptosis of human uterine leiomyoma Oncology 57 Suppl 2 1999 49 58
3. W. Chen, S. Yoshida, and N. Ohara Gonadotropin-releasing hormone antagonist cetrorelix down-regulates proliferating cell nuclear antigen and epidermal growth factor expression and up regulates apoptosis in association with enhanced poly (adenosine 5′-diphosphate-ribose) polymerase expression in cultured human leiomyoma cells J Clin Endocrinol Metab 90 2005 884 892
4. I. Sozen, and A. Arici Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata Fertil Steril 78 2002 1 12
5. K. Kawaguchi, S. Fujj, and I. Konishi Mitotic activity in uterine leiomyomas during the menstrual cycle Am J Obstet Gynecol 160 1989 637 641
6. A. Ferenczy, R.M. Richart, and T. Okagaki A comparative ultrastructural study of leiomyosarcoma, cellular leiomyoma, and leiomyoma of the uterus Cancer 28 1971 1004 1018
7. I. Lamminen, H. Rantala, and M. Helin Proliferative activity of human uterine leiomyoma cells as measured by automatic image analysis Gynecol Obstet Invest 34 1992 111 114
8. Y. Shimomura, H. Matsuo, and T. Samoto Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma J Clin Endocrinol Metab 83 1998 2192 2198
9. S.F. Cramer, A.L. Robertson, and N.P. Ziats Growth potential of human uterine leiomyomas: some in vitro observations and their implications Obstet Gynecol 66 1985 36 41
10. N.B. Upadhyaya, M.C. Doody, and P.B. Googe Histopathological changes in leiomyomata treated with leuprolide acetate Fertil Steril 54 1990 811 814
11. A.J. Tiltman The effect of progestins on the mitotic activity of uterine fibromyomas Int J Gynecol Pathol 21 1985 32 41
12. A.L. Goodman Progesterone therapy in uterine fibromyoma J Clin Endocrinol Metab 6 1946 402 408
13. A. Segaloff, J.C. Weed, and W.H. Sternberg The progesterone therapy of human uterine leiomyomas J Clin Endocrinol Metab 9 1949 1273 1291
14. T. Uchida, K. Nakakawaji, and J. Sakamato The effectiveness of medroxyprogesterone in the treatment of multiple metastasizing leiomyosarcomas: report of a case Surg Today 26 1996 138 141
15. M. Motegi, N. Takayanagi, and Y. Sando A case of so-called benign metastasizing leiomyoma responsive to progesterone [in Japanese] Nihon Kyobu Shikkan Gakkai Zasshi 31 1993 890 895
16. K. Kawaguchi, J. Fujii, and I. Konishi Ultrastructural study of cultured smooth muscle cells from uterine leiomyoma and myometrium under the influence of sex steroids Gynecol Oncol 21 1985 32 41
17. M.B. Sporn, and G.J. Todaro Autocrine secretion and malignant transformation of cells N Engl J Med 303 1980 878 880
18. E.A. Stewart, A.J. Friedman, and K. Peck Relative overexpression of collagen type 1 and collagen type 3 messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle J Clin Endocrinol Metab 79 1994 900 906
19. A. Arici, and I. Sozen Transforming growth factor-β3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation Fertil Steril 73 2000 1006 1011
20. M. Wolanska, K. Sobolewski, and M. Drozdzewicz Extracellular matrix components in uterine leiomyoma and their alteration during the tumour growth Mol Cell Endocrinol 189 1998 145 152
21. D.L. Hulboy, L.A. Rudolph, and L.M. Matrisian Matrix metalloproteinases as mediators of reproductive function Mol Hum Reprod 3 1997 27 45
22. M. Fujita Histological and biochemical studies on collagen in human uterine leiomyomas Hokkaido Igaku Zasshi 60 1985 602 615
23. U. Puistola, L. Ristili, and J. Ristili Collagen metabolism in gynecologic patients: changes in the concentration of the aminoterminal propeptide of type 3 procollagen in serum Am J Obstet Gynecol 163 1990 1276 1281
24. T. Hayakawa, K. Yamashita, and E. Ohuchi Cell-growth promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2) J Cell Sci 107 1994 2373 2379
25. Q. Dou, R.W. Tarnuzzer, and R.S. Williams Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: a mechanism for gonadotrophin releasing hormone agonist-induced tumor regression Mol Hum Reprod 3 1997 1005 1014
26. C. Ma, and N. Chegini Regulation of matrix metalloproteinases (MMPs) and their tissue inhibitors in human myometrial smooth muscle cells by TGF-β1 Mol Hum Reprod 5 1999 950 954
27. S.S. Palmer, D. Haynes-Johnson, and T. Diehl Increased expression of stromelysin 3 mRNA in leiomyomas (uterine fibroids) compared with myometrium J Soc Gynecol Invest 5 1998 203 209
28. A.B. Unden, B. Sandstedt, and K. Bruce Stromelysin-3 mRNA associated with myofibroblasts is overexpressed in aggressive basal cell carcinoma and in dermatofibroma but not in dermatofibrosarcoma J Invest Dermatol 107 1996 147 153
29. N. Inagaki, L. Ung, and T. Otani Uterine cavity matrix metalloproteinases and cytokines in patients with leiomyoma, adenomyosis or endometrial polyp Eur J Obstet Gynecol Reprod Biol 111 2003 197 203
30. Q. Dou, R.W. Tarnuzzer, and R.S. Williams Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: a mechanism for gonadotrophin releasing hormone agonist-induced tumor regression Mol Hum Reprod 3 1997 1005 1014
31. J. Massague The transforming growth factor-β family Annu Rev Cell Biol 6 1990 597 641
32. R.A. Ignotz, and J. Massague Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix J Biol Chem 261 1986 4337 4345
33. X. Luo, L. Ding, and J. Xu Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor beta Endocrinology 146 2005 1097 1118
34. 125I]TGF-β1-binding sites Endocrinology 135 1994 439 449
35. A. Arici, I. Sozen, and D. Olive Modulation of transforming growth factor-β3 (TGF-β3) expression in myometrium and leiomyoma AFS (American Fertility Society) 1994 Annual Meeting Program Supplement 1994 S31 S32
36. N. Chegini, H. Rong, and Q. Dou Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro J Clin Endocrinol Metab 81 1996 3215 3221
37. A. Arici, and I. Sozen Expression, menstrual cycle-dependent activation, and bimodal mitogenic effect of transforming growth factor beta 1 in human myometrium and leiomyoma Am J Obstet Gynecol 188 2003 76 83
38. N. Chegini, X. Luo, and L. Ding The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy Mol Cell Endocrinol 209 2003 9 16
39. J. Xu, X. Luo, and N. Chegini Differential expression, regulation and induction of Smads, transforming growth factor beta signal transduction pathway in leiomyoma and myometrial smooth muscle cells and alteration by gonadotropin-releasing hormone analog J Clin Endocrinol Metab 88 2003 1350 1361
40. K.L. Bruner, W.H. Rodgers, and L.I. Gold Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium Proc Natl Acad Sci U S A 92 1995 7362 7366
41. B.S. Lee, and R.A. Nowak Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF-beta 3 J Clin Endocrinol Metab 86 2001 913 920
42. G.D. Shipley, R.F. Tucker, and H.L. Moses Type beta transforming growth factor/growth inhibitor stimulates entry of monolayer cultures of AKR-2B cells into S phase after a prolonged prereplicative interval Proc Natl Acad Sci U S A 82 1985 4147 4151
43. R. Derynck, P.B. Lindquist, and A. Lee A new type of transforming growth factor-β, TGF-β3 EMBO J 7 1988 3737 3743
44. N. Chegini, C. Ma, and X.M. Tang Effects of GnRH analogues, add back steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor beta expression Mol Hum Reprod 12 2002 1071 1078
45. E. Battegay, E. Raines, and R. Seifert TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop Cell 63 1990 515 524
46. X. Tang, Q. Dou, and Y. Zhao The expression of transforming growth factor-Bs and TGF-B receptor mRNA and protein and the effect of TGF-Bs on human myometrial smooth muscle cells in vitro Mol Hum Reprod 3 1997 233 240
47. D.R. Edwards, G. Murphy, and J.J. Reynolds Transforming growth factor-B modulates the expression of collagenase and metalloproteinase EMBO J 6 1987 1899 1904
48. K.M. Yamada Cell surface interactions with extracellular materials Annu Rev Biochem 52 1983 761 799
49. C.J. Roberts, T.M. Birkenmeier, and J.J. McQuillan Transforming growth factor-B stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human lung fibroblasts J Biol Chem 263 1988 4586 4592
50. W.H. Catherino, P.C. Leppert, and M.H. Stenmark Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids Genes Chromosomes Cancer 40 2004 204 217
51. M.K. Skinner, and J.A. Parrott Growth factor-mediated cell-cell interactions in the ovary J.K. Findlay Molecular biology of the female reproductive system 1994 Academic Press New York
52. L.L.J. Murphy, and G. Ballejo Growth factor and cytokine expression in the endometrium J.K. Findlay Molecular biology of the female reproductive system 1994 Academic Press New York
53. G.E. Hofmann, C.V. Rao, and G.H. Barrows Binding sites for epidermal growth factor in human uterine tissues and leiomyomas J Clin Endocrinol Metab 58 1984 880 884
54. J. Yeh, M. Rein, and R. Nowak Presence of messenger ribonucleic acid for epidermal growth factor (EGF) and EGF receptor demonstrable in monolayer cell cultures of myometria and leiomyomata Fertil Steril 56 1991 997 1000
55. D. Dixon, H. He, and J.K. Haseman Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium Environ Health Perspect 108 2000 795 802
56. M.L. Harrison-Woolrych, D. Stephen, and D.S. Charnock-Jones Quantification of messenger ribonucleic acid for epidermal growth factor in human myometrium and leiomyomata using reverse transcriptase polymerase chain reaction J Clin Endocrinol Metab 78 1994 1179 1184
57. T. Maruo, H. Matsuo, and Y. Shimomura Effects of progesterone on growth factor expression in human uterine leiomyomata Steroids 68 2003 817 824
58. M.A. Lumsden, C.P. West, and R.A. Hawkins The binding of epidermal growth factor to myometrium and leiomyomata in women rendered hypo-oestrogenic by continuous administration of an LHRH agonist Br J Obstet Gynaecol 95 1988 1299 1304
59. A. Shushan, N. Rojansky, and N. Laufer The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth Hum Reprod 19 2004 1957 1967
60. K.D. Boehm, M. Daimon, and I.F. Gorodeski Expression of the insulin-like and platelet-derived growth factor genes in human uterine tissues Mol Reprod Dev 27 1990 93 101
61. Y.M. Fayed, J.C.M. Tsibris, and P.W. Langenberg Human uterine leiomyoma cells: binding and growth responses to epidermal growth factor, platelet-derived growth factor and insulin Lab Invest 60 1989 30 37
62. A. Di Lieto, M. De Falco, and F. Pollio Clinical response, vascular change, and angiogenesis in gonadotropin-releasing hormone analogue-treated women with uterine myomas J Soc Gynecol Investig 12 2005 123 128
63. A. Di Lieto, G. De Rosa, and M. De Falco Relationship between platelet-derived growth factor expression in leiomyomas and uterine volume changes after gonadotropin-releasing hormone agonist treatment Hum Pathol 33 2002 220 224
64. A. Barbarisi, O. Petillo, and A. Di Lieto 17-beta estradiol elicits an autocrine leiomyoma cell proliferation: evidence for a stimulation of protein kinase-dependent pathway J Cell Physiol 186 2001 414 424
65. B.J. Vollenhoven, A.C. Herrington, and D.L. Healy Messenger ribonucleic acid expression of the insulin-like growth factors and their binding proteins in uterine fibroids and myometrium J Clin Endocrinol Metab 76 1993 1106 1110
66. Y. Chandrasekhar, J. Heiner, and C. Osuampke Insulin-like growth factor 1 and 2 binding in human myometrium and leiomyomas Am J Obstet Gynecol 166 1992 64 69
67. M. Wolanska, and E. Bankowski An accumulation of insulin-like growth factor-1 (IGF-1) in human myometrium and uterine leiomyomas in various stages of tumor growth Eur Cytokine Netw 15 2004 359 363
68. K.D. Burroughs, S.R. Howe, and Y. Okubo Dysregulation of IGF-1 signaling in uterine leiomyoma J Endocrinol 172 2002 83 93
69. X. Wu, H. Wang, and K. Englund Expression of progesterone receptors A and B and insulin-like growth factor-1 in human myometrium and fibroids after treatment with a gonadotropin-releasing hormone analogue Fertil Steril 78 2002 985 993
70. E.B. Martin Chaves, I.S. Brum, and J. Stoll Insulin-like growth factor 1 receptor mRNA expression and autophophorylation in human myometrium and leiomyoma Gynecol Obstet Invest 57 2004 210 213
71. L.C. Giudice, J.C. Irwin, and B.A. Dsupin Insulin-like growth factor (IGF), IGF binding protein (IGFBP), and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata Hum Reprod 8 1993 1796 1806
72. T. Yamada, S. Nakago, and O. Kurachi Progesterone down-regulates insulin-like growth factor-1 expression in cultured human uterine leiomyoma cells Hum Reprod 19 2004 8 15
73. C.D. Swartz, C.A. Afshari, and L. Yu Estrogen-induced changes in IGF-1, Myb family and MAP kinase pathway genes in human uterine leiomyoma and normal uterine smooth muscle cell lines Mol Hum Reprod 11 2005 441 450
74. E.Y. Strawn, M.J. Novy, and K.A. Burry Insulin-like growth factor 1 promotes leiomyoma cell growth in vitro Am J Obstet Gynecol 172 1995 1837 1844
75. Z. Gao, H. Matsuo, and Y. Wang Up-regulation by IGF-1 of proliferating cell nuclear antigen and Bcl-2 expression in human uterine leiomyoma cells J Clin Endocrinol Metab 86 2001 5593 5596
76. M. Klagsbrun, and S. Dluz Smooth muscle cell and endothelial cell growth factors Trends Cardiovasc Med 3 1993 213 217
77. P.N. Rauk, U. Surti, and J.M. Roberts Mitogenic effect of basic fibroblast growth factor and estradiol on cultured human myometrial and leiomyoma cells Am J Obstet Gynecol 173 1995 571 577
78. R.S. Mangrulkar, M. Ono, and M. Ishikawa Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium Biol Reprod 53 1995 636 646
79. A. Di Lieto, M. De Falco, and S. Staibano Effects of gonadotropin- releasing hormone agonists on uterine volume and vasculature and on the immunohistochemical expression of basic fibroblast growth factor (bFGF) in uterine leiomyomas Int J Gynecol Pathol 22 2003 353 358
80. X. Wu, A. Blanck, and M. Olovsson Expression of basic fibroblast growth factor (bFGF), FGF receptor 1 and FGF receptor 2 in uterine leiomyomas and myometrium during the menstrual cycle, after menopause and GnRH-a treatment Acta Obstet Gynecol Scand 80 2001 497 504
81. E.C. Weir, D.I. Goad, and A.G. Daifotis Relative overexpression of the parathyroid hormone-related peptide gene in human leiomyomas Clin Endocrinol Metab 78 1994 784 789
82. M.A. Thiede, S.C. Harm, and D.M. Hasson In vivo regulation of parathyroid hormone-related peptide messenger ribonucleic acid in the rat uterus by 17B-estradiol Endocrinology 128 1991 2317 2323
83. A. Yoshizaki, T. Nakayama, and S. Naito Expressions of parathyroid hormone-related protein (PTHrP) and PTH/PTHrP-receptor (PTH/PTHrP-R) in gastrointestinal stromal tumours (GISTs), leiomyomas and schwannomas Scand J Gastroenterol 39 2004 133 137
84. M. Yoshida, A. Ohtsuru, and T. Samejima Involvement of parathyroid hormone-related peptide in cell proliferation activity of human uterine leiomyomas Endocr J 46 1999 81 90
85. D.C. Daly, C.A. Walters, and J.C. Prior Prolactin production from proliferative phase leiomyoma Am J Obstet Gynecol 148 1984 1059 1063
86. B. Gellersen, A. Bonhoff, and N. Hunt Decidual type prolactin expression by the human myometrium Endocrinology 129 1991 158 168
87. M.S. Rein, A.J. Friedman, and L.J. Heffner Decreased prolactin secretion by explant cultures of fibroids from women treated with gonadotropin-releasing hormone agonist J Clin Endocrinol Metab 70 1990 1554 1558
88. E.A. Stewart, D.J. Austin, and P. Jain RU486 suppresses prolactin production in explant cultures of leiomyoma and myometrium Fertil Steril 65 1996 1119 1124
89. D.J. Austin, R.A. Nowak, and E.A. Stewart Onapristone suppresses prolactin production in explant cultures of leiomyoma Gynecol Obstet Invest 47 1999 268 271
90. J.P. Wolf, J.G. Hsiu, and T.L. Anderson Noncompetitive antiestrogenic effect of RU486 in blocking the estrogen-stimulated luteinizing hormone surge and the proliferative action of estradiol on endometrium in castrate monkeys Fertil Steril 52 1989 1055 1060
91. K.B. Horwitz The molecular biology of RU 486: is there a role for antiprogestins in the treatment of breast cancer? Endocr Rev 13 1992 146 163
92. R.A. Nowak, S. Mora, and T. Diehl Prolactin is an autocrine or paracrine growth factor for human myometrial and leiomyoma cells Gynecol Obstet Invest 48 1999 127 132
93. S. Higashiyama, J.A. Abraham, and J. Miller A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF Science 251 1991 936 939
94. J. Wang, N. Ohara, and S. Takekida Comparative effects of heparin-binding epidermal growth factor-like growth factor on the growth of cultured human uterine leiomyoma cells and myometrial cells Hum Reprod 20 2005 1456 1465
95. I. Sozen, D. Olive, and A. Arici Expression and hormonal regulation of monocyte chemotactic protein-1 in myometrium and leiomyomata Fertil Steril 69 1998 1095 1102
96. I. Sozen, L.M. Senturk, and A. Arici Effect of gonadotropin-releasing hormone agonists on monocyte chemotactic protein-1 production and macrophage infiltration in leiomyomatous uterus Fertil Steril 76 2001 792 796
97. U. Ikeda, K. Okada, and S. Ishikawa Monocyte chemoattractant protein 1 inhibits growth of rat vascular smooth muscle cells Am J Physiol 268 1995 H1021 H1026
98. B. Battistini, P. Chailler, and P. D'orleans-Juste Growth regulatory properties of endothelins Peptides 14 1993 385 399
99. F. Pekonen, T. Nyman, and E.M. Rutanen Differential expression of mRNAs for endothelin-related proteins in human endometrium, myometrium and leiomyoma Mol Cell Endocrinol 103 1994 165 170
100. P. Robin, S. Chouayekh, and C. Bole-Feysot Contribution of phospholipase D in endothelin-1-mediated extracellular signal-regulated kinase activation and proliferation in rat uterine leiomyoma cells Biol Reprod 72 2005 69 77
101. C.C. Gentry, S.O. Okolo, and L.F. Fong Quantification of vascular endothelial growth factor-A in leiomyomas and adjacent myometrium Clin Sci 101 2001 691 695
102. M.L. Harrison-Woolrych, A.M. Sharkey, and D.S. Charnock-Jones Localization and quantification of vascular endothelial growth factor messenger ribonucleic acid in human myometrium and leiomyomata J Clin Endocrinol Metab 80 1995 1853 1858
103. D.C. Chen, J.Y. Liu, and G.J. Wu Serum vascular endothelial growth factor 165 levels and uterine fibroid volume Acta Obstet Gynecol Scand 84 2005 317 321
104. A. Horiuchi, T. Nikaido, and T. Yoshizawa HCG promotes proliferation of uterine leiomyomal cells more strongly than that of myometrial smooth muscle cells in vitro Mol Hum Reprod 6 2000 523 528
105. L.M. Senturk, I. Sozen, and L. Gutierrez Interleukin-8 production and interleukin-8 receptor expression in human myometrium and leiomyoma Am J Obstet Gynecol 184 2001 559 566
106. S.J. Tsai, S.J. Lin, and Y.M. Cheng Expression and functional analysis of pituitary tumor transforming growth factor-1 in uterine leiomyomas J Clin Endocrinol Metab 90 2005 3715 3723